Clinical Applications of Diagnostic Indocyanine Green Angiography

Retina Fifth Edition

Volumn 1, Issue , 2012, Pages 51-81

  Staurenghi, Giovanni ^a   Bottoni, Ferdinando ^a   Giani, Andrea ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906805465     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-0737-9.00002-3     Document Type: Chapter

References (125)

1. Cohen SY, Dubois L, Quentel G, et al. Is indocyanine green angiography still relevant?. Retina 2011, 31:209-221.
2. Ott P Hepatic elimination of indocyanine green with special reference to distribution kinetics and the influence of plasma protein binding. Pharmacol Toxicol 1998, 83(Suppl 2):1-48.
3. Fox IJ, Brooker LG, Heseltine DW, et al. A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Proc. Staff Meet Mayo Clin 1957, 32:478-484.
4. Fox IJ, Wood EH Applications of dilution curves recorded from the right side of the heart or venous circulation with the aid of a new indicator dye. Proc. Staff Meet Mayo Clin 1957, 32:541-550.
5. Caesar J, Shaldon S, Chiandussi L, et al. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961, 21:43-57.
6. Hunton DB, Bollman JL, Hoffman HN Studies of hepatic function with indocyanine green. Gastroenterology 1960, 39:713-724.
7. Kogure K, Choromokos E Infrared absorption angiography. J Appl Physiol 1969, 26:154-157.
8. Kogure K, David NJ, Yamanouchi U, et al. Infrared absorption angiography of the fundus circulation. Arch Ophthalmol 1970, 83:209-214.
9. Choromokos E, Kogure K, David NJ Infrared absorption angiography. J Biol Photogr Assoc 1969, 37:100-104.
10. Hochheimer BF Angiography of the retina with indocyanine green. Arch Ophthalmol 1971, 86:564-565.
11. Flower RW, Hochheimer BF Clinical infrared absorption angiography of the choroid. Am J Ophthalmol. 1972, 73:458-459.
12. Hyvarinen L, Flower RW Indocyanine green fluorescence angiography. Acta Ophthalmol (Copenh) 1980, 58:528-538.
13. Hayashi K, de Laey JJ Indocyanine green angiography of submacular choroidal vessels in the human eye. Ophthalmologica 1985, 190:20-29.
14. Hayashi K, Hasegawa Y, Tokoro T Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986, 9:37-41.
15. Hasegawa Y, Hayashi K, Tokoro T, et al. [Clinical use of indocyanine green angiography in the diagnosis of choroidal neovascular diseases.]. Fortschr Ophthalmol 1988, 85:410-412.
16. Destro M, Puliafito CA Indocyanine green videoangiography of choroidal neovascularization. Ophthalmology 1989, 96:846-853.
17. Scheider A, Schroedel C High resolution indocyanine green angiography with a scanning laser ophthalmoscope. Am J Ophthalmol 1989, 108:458-459.
18. Guyer DR, Puliafito CA, Mones JM, et al. Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology 1992, 99:287-291.
19. Yannuzzi LA, Slakter JS, Sorenson JA, et al. Digital indocyanine green videoangiography and choroidal neovascularization. Retina 1992, 12:191-223.
20. Lutty GA The acute intravenous toxicity of biological stains, dyes, and other fluorescent substances. Toxicol Appl Pharmacol 1978, 44:225-249.
21. Tripp MR, Cohen GM, Gerasch DA, et al. Effect of protein and electrolyte on the spectral stabilization of concentrated solutions of indocyanine green. Proc Soc Exp Biol Med 1973, 143:879-883.
22. Benya R, Quintana J, Brundage B Adverse reactions to indocyanine green: a case report and a review of the literature. Cathet Cardiovasc Diagn 1989, 17:231-233.
23. Bischoff PM, Flower RW Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue?. Doc Ophthalmol 1985, 60:235-291.
24. Flower RW, Hochheimer BF Indocyanine green dye fluorescence and infrared absorption choroidal angiography performed simultaneously with fluorescein angiography. Johns Hopkins Med J 1976, 138:33-42.
25. Geeraets WJ, Berry ER Ocular spectral characteristics as related to hazards from lasers and other light sources. Am J Ophthalmol 1968, 66:15-20.
26. Cherrick GR, Stein SW, Leevy CM, et al. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960, 39:592-600.
27. Leevy CM, Bender J Physiology of dye extraction by the liver: comparative studies of sulfobromophtthalein and indocyanine green. Ann N Y Acad Sci 1963, 111:161-176.
28. Stehr A, Ploner F, Traeger K, et al. Plasma disappearance of indocyanine green: a marker for excretory liver function?. Intens Care Med 2005, 31:1719-1722.
29. Costa DL, Huang SJ, Orlock DA, et al. Retinal-choroidal indocyanine green dye clearance and liver dysfunction. Retina 2003, 23:557-561.
30. Fineman MS, Maguire JI, Fineman SW, et al. Safety of indocyanine green angiography during pregnancy: a survey of the retina, macula, and vitreous societies. Arch Ophthalmol 2001, 119:353-355.
31. Hope-Ross M, Yannuzzi LA, Gragoudas ES, et al. Adverse reactions due to indocyanine green. Ophthalmology 1994, 101:529-533.
32. Speich R, Saesseli B, Hoffmann U, et al. Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med 1988, 109:345-346.
33. Michie DD, Wombolt DG, Carretta RF, et al. Adverse reactions associated with the administration of a tricarbocyanine dye (Cardio-Green) to uremic patients. J Allergy Clin Immunol 1971, 48:235-239.
34. Iseki K, Onoyama K, Fujimi S, et al. Shock caused by indocyanine green dye in chronic hemodialysis patients. Clin Nephrol 1980, 14:210.
35. Robson SC, Mutch E, Boys RJ, et al. Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance. Br J Obstet Gynaecol 1990, 97:720-724.
36. Flower RW, Csaky KG, Murphy RP Disparity between fundus camera and scanning laser ophthalmoscope indocyanine green imaging of retinal pigment epithelium detachments. Retina 1998, 18:260-268.
37. Wolf S, Wald KJ, Elsner AE, et al. Indocyanine green choroidal videoangiography: a comparison of imaging analysis with the scanning laser ophthalmoscope and the fundus camera. Retina 1993, 13:266-269.
38. Stanga PE, Lim JI, Hamilton P Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003, 110:15-21. quiz 22-3.
39. Yannuzzi LA, Flower RW, Slakter JS Indocyanine green angiography 1997, Mosby Year Book, St Louis, p. 46.
40. Hayreh SS Physiological anatomy of the choroidal vascular bed. Int Ophthalmol 1983, 6:85-93.
41. Mutoh T, Sakurai M, Tamai M Indocyanine green fundus angiography of retrobulbar vasculature. Arch Ophthalmol 1995, 113:631-633.
42. Ohno-Matsui K, Morishima N, Ito M, et al. Indocyanine green angiography of retrobulbar vascular structures in severe myopia. Am J Ophthalmol 1997, 123:494-505.
43. Gass JD Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994, 118:285-298.
44. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 1991, 109:1242-1257. Macular Photocoagulation Study Group.
45. Sadda SR, Liakopoulos S, Keane PA, et al. Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions. Graefes Arch Clin Exp Ophthalmol 2010, 248:175-184.
46. Freund KB, Ho IV, Barbazetto IA, et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008, 28:201-211.
47. Olsen TW, Feng X, Kasper TJ, et al. Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration. Ophthalmology 2004, 111:250-255.
48. Guyer DR, Yannuzzi LA, Slakter JS, et al. Classification of choroidal neovascularization by digital indocyanine green videoangiography. Ophthalmology 1996, 103:2054-2060.
49. Yannuzzi LA, Hope-Ross M, Slakter JS, et al. Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 1994, 14:99-113.
50. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006, 355:1432-1444.
51. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006, 355:1419-1431.
52. Massacesi AL, Sacchi L, Bergamini F, et al. The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2008, 246:89-92.
53. Lim JI, Aaberg TM, Capone AJ, et al. Indocyanine green angiography-guided photocoagulation of choroidal neovascularization associated with retinal pigment epithelial detachment. Am J Ophthalmol 1997, 123:524-532.
54. Watzke RC, Klein ML, Hiner CJ, et al. A comparison of stereoscopic fluorescein angiography with indocyanine green videoangiography in age-related macular degeneration. Ophthalmology 2000, 107:1601-1606.
55. Shiraga F, Ojima Y, Matsuo T, et al. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 1998, 105:662-669.
56. Staurenghi G, Orzalesi N, La Capria A, et al. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. Ophthalmology 1998, 105:2297-2305.
57. Bottoni F, Massacesi A, Cigada M, et al. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005, 123:1644-1650.
58. Flower RW Optimizing treatment of choroidal neovascularization feeder vessels associated with age-related macular degeneration. Am J Ophthalmol 2002, 134:228-239.
59. Semoun O, Guigui B, Tick S, et al. Infrared features of classic choroidal neovascularisation in exudative age-related macular degeneration. Br J Ophthalmol 2009, 93:182-185.
60. Schmidt-Erfurth U, Kriechbaum K, Oldag A Three-dimensional angiography of classic and occult lesion types in choroidal neovascularization. Invest Ophthalmol Vis Sci 2007, 48:1751-1760.
61. Hlushchuk R, Baum O, Gruber G, et al. The synergistic action of a VEGF-receptor tyrosine-kinase inhibitor and a sensitizing PDGF-receptor blocker depends upon the stage of vascular maturation. Microcirculation 2007, 14:813-825.
62. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001, 21:416-434.
63. Gass JD, Agarwal A, Lavina AM, et al. Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003, 23:741-751.
64. Hartnett ME, Weiter JJ, Staurenghi G, et al. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996, 103:2042-2053.
65. Viola F, Massacesi A, Orzalesi N, et al. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 2009, 29:732-739.
66. Rouvas AA, Papakostas TD, Vavvas D, et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 2009, 29:536-544.
67. Saito M, Shiragami C, Shiraga F, et al. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 2010, 149:472-481. e1.
68. Bottoni F, Romano M, Massacesi A, et al. Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006, 244:1528-1533.
69. Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990, 10:1-8.
70. Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995, 15:100-110.
71. Yannuzzi LA, Wong DW, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999, 117:1503-1510.
72. Ahuja RM, Stanga PE, Vingerling JR, et al. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol 2000, 84:479-484.
73. Ciardella AP, Donsoff IM, Huang SJ, et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004, 49:25-37.
74. Ahuja RM, Downes SM, Stanga PE, et al. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 2001, 108:1009-1010.
75. Yannuzzi LA, Freund KB, Goldbaum M, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000, 107:767-777.
76. Maruko I, Iida T, Saito M, et al. Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2010, 248:361-368.
77. Lai TY, Chan WM, Liu DT, et al. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008, 92:661-666.
78. Eandi CM, Ober MD, Freund KB, et al. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 2007, 27:825-831.
79. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994, 112:1057-1062.
80. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003, 23:288-298.
81. Piccolino FC, Borgia L Central serous chorioretinopathy and indocyanine green angiography. Retina 1994, 14:231-242.
82. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996, 16:203-213.
83. Shiraki K, Moriwaki M, Matsumoto M, et al. Long-term follow-up of severe central serous chorioretinopathy using indocyanine green angiography. Int Ophthalmol 1997, 21:245-253.
84. Lafaut BA, Salati C, Priem H, et al. Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp Ophthalmol 1998, 236:513-521.
85. Reibaldi M, Cardascia N, Longo A, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 2010, 149:307-315. e2.
86. Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003, 87:1453-1458.
87. Inoue R, Sawa M, Tsujikawa M, et al. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010, 149:441-446. e1-2.
88. Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina 2010, 30:801-809.
89. Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 2003, 87:709-712.
90. Prunte C, Flammer J Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996, 121:26-34.
91. Anand R, Augsburger JJ, Shields JA Circumscribed choroidal hemangiomas. Arch Ophthalmol 1989, 107:1338-1342.
92. Shields CL, Honavar SG, Shields JA, et al. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 2001, 108:2237-2248.
93. Witschel H, Font RL Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol 1976, 20:415-431.
94. Singh AD, Kaiser PK, Sears JE Choroidal hemangioma. Ophthalmol Clin North Am 2005, 18:151-161. ix.
95. Arevalo JF, Shields CL, Shields JA, et al. Circumscribed choroidal hemangioma: characteristic features with indocyanine green videoangiography. Ophthalmology 2000, 107:344-350.
96. Shields CL, Shields JA, De Potter P Patterns of indocyanine green videoangiography of choroidal tumours. Br J Ophthalmol 1995, 79:237-245.
97. Sallet G, Amoaku WM, Lafaut BA, et al. Indocyanine green angiography of choroidal tumors. Graefes Arch Clin Exp Ophthalmol 1995, 233:677-689.
98. Andersen MV, Scherfig E, Prause JU Differential diagnosis of choroidal melanomas and nevi using scanning laser ophthalmoscopical indocyanine green angiography. Acta Ophthalmol Scand 1995, 73:453-456.
99. Mueller AJ, Bartsch DU, Folberg R, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998, 116:31-39.
100. Frenkel S, Barzel I, Levy J, et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye (Lond) 2008, 22:948-952.
101. Mueller AJ, Freeman WR, Schaller UC, et al. Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology 2002, 109:2207-2214.
102. Schaller UC, Mueller AJ, Bartsch DU, et al. Choroidal melanoma microcirculation with confocal indocyanine green angiography before and 1 year after radiation brachytherapy. Retina 2000, 20:627-632.
103. Krause L, Bechrakis NE, Heinrich S, et al. Indocyanine green angiography and fluorescein angiography of malignant choroidal melanomas following proton beam irradiation. Graefes Arch Clin Exp Ophthalmol 2005, 243:545-550.
104. Midena E, Pilotto E, de Belvis V, et al. Choroidal vascular changes after transpupillary thermotherapy for choroidal melanoma. Ophthalmology 2003, 110:2216-2222.
105. Annesley WHJ Peripheral exudative hemorrhagic chorioretinopathy. Trans Am Ophthalmol Soc 1980, 78:321-364.
106. Shields CL, Salazar PF, Mashayekhi A, et al. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. Ophthalmology 2009, 116:529-535.
107. Gunduz K, Shields CL, Shields JA Varix of the vortex vein ampulla simulating choroidal melanoma: report of four cases. Retina 1998, 18:343-347.
108. Rutnin U Fundus appearance in normal eyes. I. The choroid. Am J Ophthalmol 1967, 64:821-839.
109. Osher RH, Abrams GW, Yarian D, et al. Varix of the vortex ampulla. Am J Ophthalmol 1981, 92:653-660.
110. Singh AD, De Potter P, Shields CL, et al. Indocyanine green angiography and ultrasonography of a varix of vortex vein. Arch Ophthalmol 1993, 111:1283-1284.
111. Gross NE, Yannuzzi LA, Freund KB, et al. Multiple evanescent white dot syndrome. Arch Ophthalmol 2006, 124:493-500.
112. Dell'omo R, Wong R, Marino M, et al. Relationship between different fluorescein and indocyanine green angiography features in multiple evanescent white dot syndrome. Br J Ophthalmol 2010, 94:59-63.
113. Tsukamoto E, Yamada T, Kadoi C, et al. Hypofluorescent spots on indocyanine green angiography at the recovery stage in multiple evanescent white dot syndrome. Ophthalmologica 1999, 213:336-338.
114. Slakter JS, Giovannini A, Yannuzzi LA, et al. Indocyanine green angiography of multifocal choroiditis. Ophthalmology 1997, 104:1813-1819.
115. Fardeau C, Herbort CP, Kullmann N, et al. Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology 1999, 106:1928-1934.
116. Howe LJ, Stanford MR, Graham EM, et al. Choroidal abnormalities in birdshot chorioretinopathy: an indocyanine green angiography study. Eye (Lond) 1997, 11:554-559.
117. Trinh L, Bodaghi B, Fardeau C, et al. Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families. Am J Ophthalmol 2009, 147:1042-1047. 1047.e1.
118. Park D, Schatz H, McDonald HR, et al. Indocyanine green angiography of acute multifocal posterior placoid pigment epitheliopathy. Ophthalmology 1995, 102:1877-1883.
119. Howe LJ, Woon H, Graham EM, et al. Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology 1995, 102:790-798.
120. Schneider U, Inhoffen W, Gelisken F Indocyanine green angiography in a case of unilateral recurrent posterior acute multifocal placoid pigment epitheliopathy. Acta Ophthalmol Scand 2003, 81:72-75.
121. Giovannini A, Mariotti C, Ripa E, et al. Indocyanine green angiographic findings in serpiginous choroidopathy. Br J Ophthalmol 1996, 80:536-540.
122. Amer R, Lois N Punctate inner choroidopathy. Surv Ophthalmol 2011, 56:36-53.
123. Tiffin PA, Maini R, Roxburgh ST, et al. Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol 1996, 80:90-91.
124. Levy J, Shneck M, Klemperer I, et al. Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol 2005, 40:605-608.
125. Spaide RF Collateral damage in acute zonal occult outer retinopathy. Am J Ophthalmol 2004, 138:887-889.